CN111214624A - Novel virus cold tablet - Google Patents

Novel virus cold tablet Download PDF

Info

Publication number
CN111214624A
CN111214624A CN202010267431.XA CN202010267431A CN111214624A CN 111214624 A CN111214624 A CN 111214624A CN 202010267431 A CN202010267431 A CN 202010267431A CN 111214624 A CN111214624 A CN 111214624A
Authority
CN
China
Prior art keywords
radix
traditional chinese
chinese medicine
isatidis
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010267431.XA
Other languages
Chinese (zh)
Inventor
辛永顺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guohua Pengyuan Co Ltd
Original Assignee
Guohua Pengyuan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guohua Pengyuan Co Ltd filed Critical Guohua Pengyuan Co Ltd
Priority to CN202010267431.XA priority Critical patent/CN111214624A/en
Publication of CN111214624A publication Critical patent/CN111214624A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A61K36/855—Clerodendrum, e.g. glorybower
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A61K36/195—Strobilanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315—Isatis, e.g. Dyer's woad
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538—Schizonepeta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/744—Gardenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888—Pinellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966—Fritillaria, e.g. checker lily or mission bells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/904—Stemonaceae (Stemona family), e.g. croomia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a novel virus cold tablet, which comprises the following raw material components in parts by weight: the main components are as follows: 9-15g of folium isatidis, 30-60g of purslane, 9-15g of radix isatidis, 9-15g of fructus forsythiae, 10-20g of honeysuckle, 5-10g of schizonepeta, 3-6g of mint, 6-12g of burdock, 6-12g of fermented soybean, 3-9g of platycodon grandiflorum, 5-9g of aster, 3-9g of radix stemonae, 3-9g of pinellia ternate, 3-15g of radix asparagi, 3-9g of bulbus fritilariae, 2-10g of liquorice, 3-10g of scutellaria baicalensis and 3-10g of raw gardenia, and relates to the technical field of traditional Chinese medicines. The composition can be used for treating viral influenza, and has effects in clearing away pestilence, clearing away heat and toxic materials, eliminating pathogenic factors, and improving antiviral ability, so that the patients with viral influenza have symptoms: the traditional Chinese medicine composition has the advantages that headache, fever, cough, watery nasal discharge, dry mouth, sore throat, muscular soreness of the whole body, hypodynamia and possible complications such as parotitis, pneumonia, encephalitis and the like are relieved or eliminated, and the traditional Chinese medicine composition has an inhibiting effect on upper respiratory tract infection caused by respiratory syncytial virus, rhinovirus, adenovirus, coronavirus and parainfluenza virus, so that the recovery of health of patients is accelerated.

Description

Novel virus cold tablet
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a novel virus cold tablet.
Background
Viral influenza is a common and complex exterior disease, and can be suffered from the virus in all age groups, so that the incidence rate of weak people is high. Patients with viral influenza often have symptoms of fever, headache, cough, watery nasal discharge, sore throat, general muscular soreness, hypodynamia and the like which last for days or weeks. When the patient is in the early stage of the viral cold, the patient can have fever, headache, dry mouth, pharyngalgia, cough, vomiting, general muscular soreness, hypodynamia and the like. These symptoms can occur repeatedly, so once the symptoms such as fever, headache, dry mouth, pharyngalgia, cough, general muscular soreness, hypodynamia and the like are found, a doctor needs to be seen in time to complete the management and prevention of the symptoms. If the treatment is not carried out in time, the delayed effect is that headache, cough and the like are aggravated, complications such as parotitis, pneumonia, encephalitis and the like can be generated, the whole disease process can cause the functions of the lung and the like of a patient to be damaged, particularly the functions of the lung and the like of the old and weak people are damaged and exhausted, and the life can be seriously threatened;
when the common medicines are used for treating patients with virus cold, the actions of diminishing inflammation, abating fever and relieving cough are usually only emphasized, because the medicines for clearing pestilence, clearing heat, detoxifying, expelling evil and improving the self antiviral ability are not adopted for the patients, the symptoms of the patients cannot be quickly treated, and the rehabilitation speed of the patients is seriously influenced.
Disclosure of Invention
Technical problem to be solved
Aiming at the defects of the prior art, the invention provides a novel virus cold tablet, which solves the problems that when a common medicine formula is used for treating virus cold patients, the actions of diminishing inflammation, bringing down a fever, relieving a cough and the like are often emphasized, because medicines for clearing plague, clearing heat, detoxifying, expelling evil, improving self antiviral ability are not adopted for the patients, the symptoms of the patients cannot be relieved, the virus cold patients cannot recover quickly, and the recovery speed of the patients is seriously influenced.
(II) technical scheme
In order to achieve the purpose, the invention is realized by the following technical scheme: the novel virus cold tablet comprises the following raw material components in parts by weight:
the main components are as follows: 9-15g of folium isatidis, 30-60g of purslane, 9-15g of radix isatidis, 9-15g of fructus forsythiae, 10-20g of honeysuckle, 5-10g of schizonepeta, 3-6g of mint, 6-12g of burdock, 6-12g of fermented soybean, 3-9g of platycodon grandiflorum, 5-9g of aster, 3-9g of radix stemonae, 3-9g of pinellia ternate, 3-15g of radix asparagi, 3-9g of bulbus fritilariae, 2-10g of liquorice, 3-10g of scutellaria baicalensis and 3-10g of raw gardenia;
auxiliary components: and (5) coating the sugar.
Preferably, the main components: 15g of folium isatidis, 30g of purslane, 10g of radix isatidis, 12g of fructus forsythiae, 15g of honeysuckle, 6g of herba schizonepetae, 3g of mint, 6g of burdock, 10g of fermented soybean, 9g of platycodon grandiflorum, 9g of aster, 9g of radix stemonae, 6g of pinellia ternate, 10g of radix asparagi, 6g of bulbus fritilariae, 6g of liquorice, 10g of scutellaria baicalensis and 6g of raw gardenia;
auxiliary components: and (5) coating the sugar.
Preferably, the main components: 15g of folium isatidis, 30g of purslane, 9g of radix isatidis, 10g of fructus forsythiae, 12g of honeysuckle, 5g of herba schizonepetae, 3g of mint, 6g of burdock, 8g of fermented soybean, 8g of platycodon grandiflorum, 9g of aster, 9g of radix stemonae, 5g of pinellia ternate, 10g of radix asparagi, 6g of bulbus fritillariae cirrhosae, 8g of liquorice, 10g of radix scutellariae and 6g of raw gardenia;
auxiliary components: and (5) coating the sugar.
Preferably, the main components: 12g of folium isatidis, 30g of purslane, 9g of radix isatidis, 10g of fructus forsythiae, 10g of honeysuckle, 5g of herba schizonepetae, 3g of mint, 6g of burdock, 12g of fermented soybean, 3g of platycodon grandiflorum, 8g of aster, 8g of radix stemonae, 5g of pinellia ternate, 10g of radix asparagi, 6g of bulbus fritillariae cirrhosae, 7g of liquorice, 8g of scutellaria baicalensis and 5g of raw gardenia;
auxiliary components: and (5) coating the sugar.
Preferably, the main components: 10g of folium isatidis, 30g of purslane, 9g of radix isatidis, 9g of fructus forsythiae, 10g of honeysuckle, 5g of herba schizonepetae, 4g of mint, 6g of burdock, 8g of fermented soybean, 5g of platycodon grandiflorum, 7g of aster, 7g of radix stemonae, 4g of pinellia ternate, 8g of radix asparagi, 4g of bulbus fritillariae cirrhosae, 6g of liquorice, 5g of scutellaria baicalensis and 6g of raw gardenia;
auxiliary components: and (5) coating the sugar.
The invention also discloses a traditional Chinese medicine technical preparation method of the novel virus cold tablet, which comprises the following steps:
step 1: preparing a medicine:
taking out folium Isatidis, herba Portulacae, radix Isatidis, fructus forsythiae, flos Lonicerae, herba Schizonepetae, herba Menthae, fructus Arctii, semen Sojae Preparatum, radix Platycodi, radix Asteris, radix Stemonae, rhizoma Pinelliae, radix asparagi, Bulbus Fritillariae Cirrhosae, Glycyrrhrizae radix, Scutellariae radix, and fructus Gardeniae from pharmacy, placing the taken out Chinese medicinal materials in the equipment, and simultaneously penetrating the surface of the Chinese medicinal materials to determine whether there is bug or insect ovum;
step 2: basic treatment of the medicine:
placing the medicines inside the washing basket, placing a cleaning basin at the bottom of the washing basket, opening a water tap, quickly rinsing the traditional Chinese medicine medicines, and quickly taking out the washing basket;
and step 3: drying and sterilizing;
and 4, step 4: selecting optimized granulating and tabletting process, and screening appropriate film coating agent and coating process to treat the traditional Chinese medicine.
Preferably, in the step 4, when the tabletting, film coating agent and coating process are carried out on the medicine, a device which is easy to react with the effective components in the medicine is forbidden to use non-food odorous auxiliary materials and metal objects;
preferably, in the step 4, tablets are prepared, wherein each tablet of the film-coated tablets weighs 0.31 g, and each tablet core of the sugar-coated tablets weighs 0.3 g.
(III) advantageous effects
The invention provides a novel virus cold tablet. Compared with the prior art, the method has the following beneficial effects:
(1) the novel virus cold tablet comprises 9-15g of folium isatidis, 30-60g of purslane, 9-15g of radix isatidis, 9-15g of fructus forsythiae, 10-20g of honeysuckle, 5-10g of herba schizonepetae, 3-6g of mint, 6-12g of burdock, 6-12g of fermented soybean, 3-9g of platycodon grandiflorum, 5-9g of aster, 3-9g of radix stemonae, 3-9g of pinellia ternate, 3-15g of radix asparagi, 3-9g of bulbus fritillariae cirrhosae, 2-10g of liquorice, 3-10g of radix scutellariae and 3-10g of raw gardenia, so that the novel virus cold tablet can effectively carry out antipyretic, heat clearing, detoxifying, pathogen expelling and self-antiviral abilities on virus cold patients, and can cause headache, fever, cough, vomiting and watery nasal discharge of the virus cold patients, The oral cavity dryness, throat pain, general muscular soreness, hypodynamia and possible complications such as parotitis, pneumonia, encephalitis and the like are relieved or disappeared, and the oral cavity health care liquid has an inhibiting effect on upper respiratory tract infection caused by respiratory syncytial virus, rhinovirus, adenovirus, coronavirus and parainfluenza virus, so that the recovery of patients is accelerated;
(2) this novel virus cold tablet for effective component in the traditional chinese medicine can be by furthest's extraction, great improvement the effective extraction ability of traditional chinese medicine, through step 4's preparation, make this medicine in the manufacturing process, can be further with effective component in the medicine through separating, the method of preforming is appeared it, and the step operation is comparatively simple, easily staff maintains.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The embodiment of the invention provides four technical schemes: the preparation method of the novel virus cold tablet specifically comprises the following embodiments:
example 1
Step 1: preparing a medicine:
taking 15g of folium isatidis, 30g of purslane, 10g of radix isatidis, 12g of fructus forsythiae, 15g of honeysuckle, 6g of herba schizonepetae, 3g of mint, 6g of burdock, 10g of fermented soybean, 9g of platycodon grandiflorum, 9g of aster, 9g of radix stemonae, 6g of pinellia ternate, 10g of radix asparagi, 6g of bulbus fritilariae, 6g of liquorice, 10g of scutellaria baicalensis and 6g of raw gardenia from a pharmacy, placing the taken traditional Chinese medicine in equipment, and penetrating through the surface of the traditional Chinese medicine to determine whether insects or not exist;
step 2: basic treatment of the medicine:
placing the medicines inside the washing basket, placing a cleaning basin at the bottom of the washing basket, opening a water tap, quickly rinsing the traditional Chinese medicine medicines, and quickly taking out the washing basket;
and step 3: drying and sterilizing;
and 4, step 4: selecting optimized granulating and tabletting process, and screening appropriate film coating agent and coating process to treat the traditional Chinese medicine.
Example 2
Step 1: preparing a medicine:
taking 15g of folium isatidis, 30g of purslane, 9g of radix isatidis, 10g of fructus forsythiae, 12g of honeysuckle, 5g of herba schizonepetae, 3g of mint, 6g of burdock, 8g of fermented soybean, 8g of platycodon grandiflorum, 9g of aster, 9g of radix stemonae, 5g of pinellia ternate, 10g of radix asparagi, 6g of bulbus fritilariae, 8g of liquorice, 10g of scutellaria baicalensis and 6g of raw gardenia from a pharmacy, placing the taken traditional Chinese medicine in equipment, and penetrating through the surface of the traditional Chinese medicine to determine whether insects or not exist;
step 2: basic treatment of the medicine:
placing the medicines inside the washing basket, placing a cleaning basin at the bottom of the washing basket, opening a water tap, quickly rinsing the traditional Chinese medicine medicines, and quickly taking out the washing basket;
and step 3: drying and sterilizing;
and 4, step 4: selecting optimized granulating and tabletting process, and screening appropriate film coating agent and coating process to treat the traditional Chinese medicine.
Example 3
Step 1: preparing a medicine:
taking 12g of folium isatidis, 30g of purslane, 9g of radix isatidis, 10g of fructus forsythiae, 10g of honeysuckle, 5g of herba schizonepetae, 3g of mint, 6g of burdock, 12g of fermented soybean, 3g of platycodon grandiflorum, 8g of aster, 8g of radix stemonae, 5g of pinellia ternate, 10g of radix asparagi, 6g of bulbus fritillariae cirrhosae, 7g of liquorice, 8g of scutellaria baicalensis and 5g of raw gardenia from a pharmacy, placing the taken traditional Chinese medicine in equipment, and penetrating through the surface of the traditional Chinese medicine to determine whether insects or not exist;
step 2: basic treatment of the medicine:
placing the medicines inside the washing basket, placing a cleaning basin at the bottom of the washing basket, opening a water tap, quickly rinsing the traditional Chinese medicine medicines, and quickly taking out the washing basket;
and step 3: drying and sterilizing;
and 4, step 4: selecting optimized granulating and tabletting process, and screening appropriate film coating agent and coating process to treat the traditional Chinese medicine.
Example 4
Step 1: preparing a medicine:
taking 10g of folium isatidis, 30g of purslane, 9g of radix isatidis, 9g of fructus forsythiae, 10g of honeysuckle, 5g of herba schizonepetae, 4g of mint, 6g of burdock, 8g of fermented soybean, 5g of platycodon grandiflorum, 7g of aster, 7g of radix stemonae, 4g of pinellia ternate, 8g of radix asparagi, 4g of bulbus fritilariae, 6g of liquorice, 5g of scutellaria baicalensis and 6g of raw gardenia from a pharmacy, placing the taken traditional Chinese medicine in equipment, and penetrating through the surface of the traditional Chinese medicine to determine whether insects or not exist;
step 2: basic treatment of the medicine:
placing the medicines inside the washing basket, placing a cleaning basin at the bottom of the washing basket, opening a water tap, quickly rinsing the traditional Chinese medicine medicines, and quickly taking out the washing basket;
and step 3: drying and sterilizing;
and 4, step 4: selecting optimized granulating and tabletting process, and screening appropriate film coating agent and coating process to treat the traditional Chinese medicine.
The simple replacement of part of the traditional Chinese medicine components for realizing the same functions belongs to the technical scope to be protected by the invention.
Actual data
According to the claims of the existing manufacturers, four different novel virus cold tablets can be manufactured, after four groups of novel virus cold tablets are subjected to cleaning treatment, the cure rate and the number of cured patients of the four groups of novel virus cold tablets are actually recorded, the number of the patients in each group is recorded as 50 in time, and the table 1 shows that the weight of the novel virus cold tablets in the four embodiments is recorded through actual data, so that the number of the patients with different degrees is cured, the weight of the novel virus cold tablets is the same as the number of the patients with different degrees, therefore, the weight of the novel virus cold tablets is the same as the effect of curing the patients with different degrees, and the effect is as high as 98%;
table 1: novel virus cold tablet composition weight, disease state degree and cured patient number table
Figure 981610DEST_PATH_IMAGE002
It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.

Claims (8)

1. The novel virus cold tablet is characterized in that: the components of the raw materials and the weight parts of each component are as follows:
the main components are as follows: 9-15g of folium isatidis, 30-60g of purslane, 9-15g of radix isatidis, 9-15g of fructus forsythiae, 10-20g of honeysuckle, 5-10g of schizonepeta, 3-6g of mint, 6-12g of burdock, 6-12g of fermented soybean, 3-9g of platycodon grandiflorum, 5-9g of aster, 3-9g of radix stemonae, 3-9g of pinellia ternate, 3-15g of radix asparagi, 3-9g of bulbus fritilariae, 2-10g of liquorice, 3-10g of scutellaria baicalensis and 3-10g of raw gardenia;
auxiliary components: and (5) coating the sugar.
2. The novel viral influenza tablet according to claim 1, wherein:
the main components are as follows: 15g of folium isatidis, 30g of purslane, 10g of radix isatidis, 12g of fructus forsythiae, 15g of honeysuckle, 6g of herba schizonepetae, 3g of mint, 6g of burdock, 10g of fermented soybean, 9g of platycodon grandiflorum, 9g of aster, 9g of radix stemonae, 6g of pinellia ternate, 10g of radix asparagi, 6g of bulbus fritilariae, 6g of liquorice, 10g of scutellaria baicalensis and 6g of raw gardenia;
auxiliary components: and (5) coating the sugar.
3. The novel viral influenza tablet according to claim 1, wherein:
the main components are as follows: 15g of folium isatidis, 30g of purslane, 9g of radix isatidis, 10g of fructus forsythiae, 12g of honeysuckle, 5g of herba schizonepetae, 3g of mint, 6g of burdock, 8g of fermented soybean, 8g of platycodon grandiflorum, 9g of aster, 9g of radix stemonae, 5g of pinellia ternate, 10g of radix asparagi, 6g of bulbus fritillariae cirrhosae, 8g of liquorice, 10g of radix scutellariae and 6g of raw gardenia;
auxiliary components: and (5) coating the sugar.
4. The novel viral influenza tablet according to claim 1, wherein:
the main components are as follows: 12g of folium isatidis, 30g of purslane, 9g of radix isatidis, 10g of fructus forsythiae, 10g of honeysuckle, 5g of herba schizonepetae, 3g of mint, 6g of burdock, 12g of fermented soybean, 3g of platycodon grandiflorum, 8g of aster, 8g of radix stemonae, 5g of pinellia ternate, 10g of radix asparagi, 6g of bulbus fritillariae cirrhosae, 7g of liquorice, 8g of scutellaria baicalensis and 5g of raw gardenia;
auxiliary components: and (5) coating the sugar.
5. The novel viral influenza tablet according to claim 1, wherein:
the main components are as follows: 10g of folium isatidis, 30g of purslane, 9g of radix isatidis, 9g of fructus forsythiae, 10g of honeysuckle, 5g of herba schizonepetae, 4g of mint, 6g of burdock, 8g of fermented soybean, 5g of platycodon grandiflorum, 7g of aster, 7g of radix stemonae, 4g of pinellia ternate, 8g of radix asparagi, 4g of bulbus fritillariae cirrhosae, 6g of liquorice, 5g of scutellaria baicalensis and 6g of raw gardenia;
auxiliary components: and (5) coating the sugar.
6. The traditional Chinese medicine technology preparation of the novel virus cold tablet is characterized in that: the method comprises the following steps:
step 1: preparing a medicine: taking out from a pharmacy: the preparation method comprises the following steps of (1) placing the taken traditional Chinese medicine into equipment, and simultaneously penetrating through the surface of the traditional Chinese medicine to determine whether worms or insect eggs exist;
step 2: basic treatment of the medicine: placing the medicine in the washing basket, and placing the cleaning agent at the bottom of the washing basket
A wash basin, wherein a tap is opened, and the wash basket is quickly taken out after the traditional Chinese medicine is quickly rinsed;
and step 3: drying and sterilizing;
and 4, step 4: selecting optimized granulating and tabletting process, and screening appropriate film coating agent and coating process to treat the traditional Chinese medicine.
7. The method for producing a novel viral influenza tablet according to claim 6, wherein: in the step 4, when the medicine is subjected to tabletting, film coating and coating processes, instruments which are easy to react with effective components in the medicine are forbidden to use non-food flavored additive auxiliary materials and metal articles.
8. The method for producing a novel viral influenza tablet according to claim 6, wherein: and 4, preparing tablets, wherein each tablet of the film-coated tablets weighs 0.31 g, and each tablet core of the sugar-coated tablets weighs 0.3 g.
CN202010267431.XA 2020-04-08 2020-04-08 Novel virus cold tablet Pending CN111214624A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010267431.XA CN111214624A (en) 2020-04-08 2020-04-08 Novel virus cold tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010267431.XA CN111214624A (en) 2020-04-08 2020-04-08 Novel virus cold tablet

Publications (1)

Publication Number Publication Date
CN111214624A true CN111214624A (en) 2020-06-02

Family

ID=70807986

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010267431.XA Pending CN111214624A (en) 2020-04-08 2020-04-08 Novel virus cold tablet

Country Status (1)

Country Link
CN (1) CN111214624A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111569025A (en) * 2020-06-15 2020-08-25 国华鹏源股份有限公司 Novel virus-removing tablet
CN111939211A (en) * 2020-07-17 2020-11-17 深圳市老年医学研究所 Traditional Chinese medicine composition for adjuvant therapy of middle-stage neocoronary infection and preparation method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1504232A (en) * 2001-11-12 2004-06-16 北京中医药大学 Separating preparation process of effective part and active component of influenza virus resisting medicine
CN1631390A (en) * 2003-12-22 2005-06-29 王建国 Dripping pills for treating viral cold
CN1660368A (en) * 2005-01-31 2005-08-31 北京正大绿洲医药科技有限公司 Oral drop pill in use for clearing away heat and toxic material and preparation method
CN101690745A (en) * 2009-10-30 2010-04-07 福州市仓山区金点子信息咨询有限公司 Chinese medicinal composition for preventing and treating flu
CN102988469A (en) * 2012-12-06 2013-03-27 上海中医药大学 Traditional Chinese medicine composition for preventing and treating influenza virus infection as well as preparation method and application thereof
CN103505654A (en) * 2013-09-27 2014-01-15 广东恒诚制药有限公司 Compound traditional Chinese medicine preparation for resisting influenza viruses
CN110876782A (en) * 2019-11-29 2020-03-13 辛永顺 Swelling-diminishing pain-relieving gout soup

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1504232A (en) * 2001-11-12 2004-06-16 北京中医药大学 Separating preparation process of effective part and active component of influenza virus resisting medicine
CN1631390A (en) * 2003-12-22 2005-06-29 王建国 Dripping pills for treating viral cold
CN1660368A (en) * 2005-01-31 2005-08-31 北京正大绿洲医药科技有限公司 Oral drop pill in use for clearing away heat and toxic material and preparation method
CN101690745A (en) * 2009-10-30 2010-04-07 福州市仓山区金点子信息咨询有限公司 Chinese medicinal composition for preventing and treating flu
CN102988469A (en) * 2012-12-06 2013-03-27 上海中医药大学 Traditional Chinese medicine composition for preventing and treating influenza virus infection as well as preparation method and application thereof
CN103505654A (en) * 2013-09-27 2014-01-15 广东恒诚制药有限公司 Compound traditional Chinese medicine preparation for resisting influenza viruses
CN110876782A (en) * 2019-11-29 2020-03-13 辛永顺 Swelling-diminishing pain-relieving gout soup

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"银翘解毒颗粒临床应用解析", 《中国社区医师》 *
周德生等: "《中医名方全书（珍藏本）超值版》", 30 August 2012, 湖南科学技术出版社 *
石钺等: "银翘散抗流感病毒有效部位群化学成分的分离与鉴定", 《中国中药杂志》 *
谢斌等: "银翘散对多种呼吸道病毒作用体外实验研究", 《中国热带医学》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111569025A (en) * 2020-06-15 2020-08-25 国华鹏源股份有限公司 Novel virus-removing tablet
CN111939211A (en) * 2020-07-17 2020-11-17 深圳市老年医学研究所 Traditional Chinese medicine composition for adjuvant therapy of middle-stage neocoronary infection and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101461911B (en) Chinese medicine oral capsule for treating gout
CN104367796B (en) A kind of Chinese medicine composition for treating canker sore
CN111214624A (en) Novel virus cold tablet
CN107050338A (en) Chinese medicine composition and preparation method for treating chronic pharyngitis
CN102688437B (en) Traditional Chinese medicine for treatment of bronchitis and preparation method thereof
CN101439164A (en) Method for preparing Chinese medicine for treating sthenia fire type aphtha
CN103656410B (en) A kind of Chinese medicine preparation for the treatment of cough and preparation method thereof
CN103721197A (en) Traditional Chinese medicine for treating chronic pharyngitis
CN102406863B (en) Chinese medicine composition for treating leukorrhagia
CN105943963A (en) Medicine for treating pig pneumonia
CN109316551A (en) A kind of Chinese medicine composition and preparation method thereof for treating acpuei pharyngitis
CN102961643A (en) Traditional Chinese medicine preparation for treating bronchiectasis
CN107898887A (en) A kind of Chinese medicine for treating helicobacter pylori
CN114917297B (en) Medicine for severe acute exacerbation of chronic obstructive pulmonary disease and preparation method thereof
CN116492432B (en) Traditional Chinese medicine mixture for treating lung syndrome caused by pathogenic heat of virus infection
CN103223075B (en) Traditional Chinese medicinal capsule for treating diphtheria
CN102579885B (en) Chinese herbal medicament for treating recurrent oral ulcer
CN111569025A (en) Novel virus-removing tablet
CN101797343A (en) Chinese medicinal formula for treating oral cavity and throat diseases
CN102614480A (en) Traditional Chinese medicine lotion preparation method for curing stomach-yin deficiency ecthyma
CN103989953A (en) Traditional Chinese medicinal composition for treating infantile paralysis
CN104398578A (en) Astragalus membranaceus capsule used for treating bronchial asthma and capable of diffusing lung and calming panting
CN104257956A (en) Traditional Chinese medicine composition with effects of relieving cough and asthma
CN113181288A (en) Traditional Chinese medicine composition for treating chronic cough and preparation method and application thereof
CN109078068A (en) A kind of cold drug and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination